Development of invasive follicular cell carcinomas in a rat thyroid carcinogenesis model: Biological impact of capsular inflammation and reduced cyclooxygenase-2 expression

Cancer Science

Volumn 96, Issue 1, 2005, Pages 31-37

  Imai, Toshio ^a   Hasumura, Mai ^a   Onose, Jun Ichi ^a   Ueda, Makoto ^a   Takizawa, Tamotsu ^a   Cho, Young Man ^a   Hirose, Masao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; BIS(2 HYDROXYPROPYL)NITROSAMINE; CYCLOOXYGENASE 2; DRINKING WATER; PROPYLTHIOURACIL; SULFADIMETHOXINE; ANTIINFECTIVE AGENT; CARCINOGEN; ENZYME INHIBITOR; IODIDE PEROXIDASE; NITROSAMINE; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID HYPERPLASIA; THYROIDITIS; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; FISCHER 344 RAT; INFLAMMATION; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ANIMALS; ANTI-INFECTIVE AGENTS; ANTITHYROID AGENTS; BLOTTING, WESTERN; CARCINOGENS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; IODIDE PEROXIDASE; MALE; NITROSAMINES; PROPYLTHIOURACIL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFADIMETHOXINE; THYROID NEOPLASMS;

EID: 14144250090     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00002.x     Document Type: Article

References (35)

1. Mitsumori K, Onodera H, Takahashi M, Shimo T, Yasuhara K, Kitaura K, Hayashi Y. Effect of thyroid stimulating hormone on the development and progression of rat thyroid follicular cell tumors. Cancer Lett 1995; 92: 193-202.
2. Hood A, Liu YP, Gattone VH. 2nd, Klaassen CD. Sensitivity of thyroid gland growth to thyroid stimulating hormone (TSH) in rats treated with antithyroid drugs. Toxicol Sci 1999; 49: 263-71.
3. Imai T, Onose J, Hasumura M, Ueda M, Takizawa T, Hirose M. Sequential analysis of development of invasive thyroid follicular cell carcinomas in inflamed capsular regions of rats treated with sulfadimethoxine after N-bis (2-hydroxypropyl) nitrosamine-initiation. Toxicol Pathol 2004; 32: 229-36.
4. Hiasa Y, Kitahori Y, Kato Y, Ohshima M, Konishi N, Shimoyama T, Sakaguchi Y, Hashimoto H, Minami S, Murata Y. Potassium perchlorate, potassium iodide, and propylthiouracil: promoting effect on the development of thyroid tumors in rats treated with N-bis (2-hydroxypropyl) nitrosamine. Jpn J Cancer Res 1987; 78: 1335-40.
5. Ohki S, Ogino N, Yamamoto S, Hayaishi O. Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem 1979; 254: 829-36.
6. Yokoyama C, Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989; 165: 888-94.
7. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992; 89: 7384-8.
8. Kennedy BP, Chan CC, Culp SA, Cromlish WA. Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Biochem Biophys Res Commun 1993; 197: 494-500.
9. Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 1993; 307 361-8.
10. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271 33157-60.
11. Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 1998; 90: 1609-20.
12. Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 2002; 190: 279-86.
13. Hardisty JF, Boorman GA. Thyroid gland. In: Boorman GA, Eustis SL, Elwell MR, Montgomery CA Jr, MacKenzie AT (eds). Pathology of the Fischer Rat. Academic Press, San Diego 1990; 519-36.
14. Gianoukakis AG, Cao HJ, Jennings TA, Smith TJ. Prostaglandin endoperoxide H synthase expression in human thyroid epithelial cells. Am J Physiol Cell Physiol 2001; 280: C701-8.
15. Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 2001; 61: 1927-33.
16. Wollman SH, Herveg JP. Thyroid capsule changes during the development of thyroid hyperplasia in the rat. Am J Pathol 1978; 93: 639-54.
17. Ng HP, Banga JP, Kung AW. Development of a marine model of autoimmune thyroiditis induced with homologous mouse thyroid peroxidase. Endocrinology 2004; 145: 809-16.
18. Gentile F, Conte M, Formisano S. Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure? Immunology 2004; 112: 13-25.
19. Kuliawat R, Lisand MP, Arvan P. Polarized distribution and delivery of plasma membrane proteins in thyroid follicular epithelial cells. J Biol Chem 1995; 270: 2478-82.
20. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18: 7908-16.
21. Fukutake M, Nakatsugi S, Isoi T, Takahashi M, Ohta T, Mamiya S, Taniguchi Y, Sato H, Fukuda K, Sugimura T, Wakabayashi K. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis 1998; 19: 1939-42.
22. Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 2001; 281: F1-11.
23. Sorli CH, Zhang HJ, Armstrong MB, Rajotte RV, Maclouf J, Robertson RP. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci USA 1998; 95: 1788-93.
24. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 1996; 93: 2317-21.
25. Bazan NG, Lukiw WJ. Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem 2002; 277: 30359-67.
26. Sirois J, Richards JS. Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Evidence for the role of a cis- acting C/EBP beta promoter element. J Biol Chem 1993; 268: 21931-8.
27. Narko, K, Ritvos O, Ristimaki A. Induction of cyclooxygenase-2 and prostaglandin F2alpha receptor expression by interleukin-1beta in cultured human granulosa-luteal cells. Endocrinology 1997; 138: 3638-44.
28. Smith TJ, Jennings TA, Sciaky D, Cao HJ. Prostaglandin-endoperoxide H synthase-2 expression in human thyroid epithelium. Evidence for constitutive expression in vivo and in cultured KAT-50 cells. J Biol Chem 1999; 274: 15622-32.
29. Robertson RP. Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes 1998; 47 1379-83.
30. Cornetta AJ, Russell JP, Cunnane M, Keane WM, Rothstein JL. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis. Laryngoscope 2002; 112: 238-42.
31. Specht MC, Tucker ON, Hocever M, Gonzalez D, Teng L, Fahey TJ, III. Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab 2002; 87: 358-63.
32. Ito Y, Yoshida H, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A. Cyclooxygenase-2 expression in thyroid neoplasms. Histopathology 2003; 42: 492-7.
33. Nose F, Ichikawa T, Fujiwara M, Okayasu I. Up-regulation of cyclooxygenase-2 expression in lymphocytic, thyroiditis and thyroid tumors: significant correlation with inducible nitric oxide synthase. Am J Clin Pathol 2002; 117: 546-51.
34. Trifan OC, Smith RM, Thompson BD, Hla T. Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. J Biol Chem 1999; 274: 34141-7.
35. Zahner G, Wolf G, Ayoub M, Reinking R, Panzer U, Shankland SJ, Stahl RA. Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27 kip-1. J Biol Chem 2002; 277: 9763-71.